Latin America Crispr And Cas Genes Market Size & Outlook
Latin America crispr and cas genes market, 2018-2030 (US$M)
Related Markets
Latin America crispr and cas genes market highlights
- The Latin America crispr and cas genes market generated a revenue of USD 145.7 million in 2023.
- The market is expected to grow at a CAGR of 16.4% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2024 to 2030.
Latin America data book summary
| Market revenue in 2023 | USD 145.7 million |
| Market revenue in 2030 | USD 420.5 million |
| Growth rate | 16.4% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
| Key market players worldwide | AstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics |
Other key industry trends
- In terms of revenue, Latin America region accounted for 4.6% of the global crispr and cas genes market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,461.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CRISPR And Cas Genes Market Scope
CRISPR And Cas Genes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America crispr and cas genes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crispr and cas genes market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 78.38% in 2023. Horizon Databook has segmented the Latin America crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
The region requires high investment to boost innovation and Intellectual Property (IP) developments pertaining to DNA modification. Presence of major gene-based diseases, along with an increased number of training workshops undertaken by scientists and researchers in the region, is expected to increase Latin America’s demand for CRISPR and Cas genes.
Gene therapy is expected to ease the social and financial burden of various medical conditions in the region, thereby boosting the demand for CRISPR technology. Latin America is engaged in the large-scale production of Genetically Modified (GM) crops.
Extensive research pertaining to CRISPR technology and experimenting to make bananas resistant to a strain of deadly fungus, ravaging plantations in Latin America, is expected to pave the way for numerous opportunities.
Reasons to subscribe to Latin America crispr and cas genes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America crispr and cas genes market databook
-
Our clientele includes a mix of crispr and cas genes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America crispr and cas genes market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America crispr and cas genes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America crispr and cas genes market size, by country, 2018-2030 (US$M)
Latin America CRISPR And Cas Genes Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
